Kamran Qureshi
Overview
Explore the profile of Kamran Qureshi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
233
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jaan A, Shahnoor S, Khan A, Farooq U, Muhammad Q, Qureshi K
Clin Res Hepatol Gastroenterol
. 2025 Feb;
49(4):102554.
PMID: 39947287
Aims: Alcoholic hepatitis (AH), a clinical syndrome precipitated by chronic alcohol consumption, constitutes about 0.9 % of total admissions in the United States. It presents a wide severity spectrum, from...
2.
Jaber F, Abuelazm M, Soliman Y, Madi M, Abusuilik H, Amin A, et al.
Liver Transpl
. 2025 Jan;
PMID: 39868927
Background: Machine perfusion (MP), including hypothermic oxygenated machine perfusion (HOPE), dual HOPE, normothermic machine perfusion (NMP), NMP ischemia-free liver transplantation (NMP-ILT), and controlled oxygenated rewarming (COR), is increasingly being investigated...
3.
Malik S, Frey L, Gutman J, Mushtaq A, Warraich F, Qureshi K
Am J Gastroenterol
. 2024 Dec;
PMID: 39688962
Introduction: Recent advancements in artificial intelligence (AI), particularly through the deployment of large language models (LLMs), have profoundly impacted healthcare. This study assesses 5 LLMs-ChatGPT 3.5, ChatGPT 4, BARD, CLAUDE,...
4.
Shiffman M, Reddy K, Leise M, Qureshi K, Smith A, Helmke S, et al.
Aliment Pharmacol Ther
. 2024 Nov;
61(1):75-87.
PMID: 39523681
Background: The accuracy of current criteria for ruling out large oesophageal varices (LEV) and other endoscopic lesions of portal hypertension (PH) may be compromised by obesity and MASLD/MASH. Aims: In...
5.
Manithody C, Denton C, Mehta S, Carter J, Kurashima K, Bagwe A, et al.
Am J Physiol Gastrointest Liver Physiol
. 2024 Aug;
327(5):G640-G654.
PMID: 39163019
Total parenteral nutrition (TPN) provides lifesaving nutritional support intravenously; however, it is associated with significant side effects. Given gut microbial alterations noted with TPN, we hypothesized that transferring fecal microbiota...
6.
Farooq U, Tarar Z, El Alayli A, Kamal F, Niu C, Qureshi K
J Gastroenterol Hepatol
. 2023 Nov;
39(3):560-567.
PMID: 37953474
Background: Hepatorenal syndrome (HRS) frequently complicates alcoholic hepatitis (AH) and portends poor survival in this population. Published literature indicates mixed benefits from renal replacement therapy (RRT) for HRS refractory to...
7.
Elbeshbeshy H, Modi N, Patel T, Matthews I, Kampert T, Lee J, et al.
Clin Transplant
. 2023 Oct;
38(1):e15161.
PMID: 37842872
Background: With the introduction of direct-acting antiviral therapies (DAAs), the non-use rate of hepatitis C virus (HCV)-positive donor organs (D+) has decreased significantly. We present the donor, recipient, and transplant...
8.
Nwankwo Jr E, Burton S, Brotherton T, Carpenter D, Qureshi K
ACG Case Rep J
. 2022 Nov;
9(11):e00899.
PMID: 36447767
Primary hepatic leiomyomas are rare tumors most commonly in immunosuppressed individuals who are coinfected with Epstein-Barr virus (EBV). From our literature review, there have been 50 published cases, of which...
9.
10.
Qureshi K, Neuschwander-Tetri B
Expert Opin Investig Drugs
. 2019 Dec;
29(2):151-161.
PMID: 31847612
: Nonalcoholic steatohepatitis (NASH) is a leading cause of liver disease in children and adults, a major contributor to health-care expenditures, and now a leading reason for liver transplantation. Adopting...